Prevalence and correlates of cannabis use among individuals with DSM-5 social anxiety disorder: Findings from a nationally representative sample

J Psychiatr Res. 2023 Jul:163:406-412. doi: 10.1016/j.jpsychires.2023.05.079. Epub 2023 May 30.

Abstract

Cannabis use disorder (CUD) and frequency of use are highly related to social anxiety disorder (SAD). With updates to diagnostic criteria of psychiatric disorders and recent changes in cannabis laws, the present study sought to explore the relationships between cannabis use, CUD, and social anxiety in a large nationally representative sample of individuals with lifetime (N = 1255) and past-year SAD (N = 980). Notably, we found that at the symptom level, at least weekly cannabis use was significantly related to fear or avoidance of social situations interfering with relationships in both samples. Weekly + cannabis use and CUD were significantly associated with lifetime SAD symptom severity, but only weekly + cannabis use was related to SAD severity in the past-year sample. We also found that weekly + cannabis use but not CUD was related to greater odds of seeking treatment for SAD and suicide attempt history. Overall, these data provide an updated examination of cannabis use and SAD using DSM-5 criteria and a large nationally representative sample and also highlight the importance of weekly + cannabis use as a marker of severity and suicide risk in individuals with SAD.

Keywords: Cannabis use disorder; Social anxiety disorder; Suicide; Treatment seeking.

MeSH terms

  • Cannabis*
  • Comorbidity
  • Humans
  • Marijuana Abuse* / diagnosis
  • Marijuana Abuse* / epidemiology
  • Phobia, Social* / diagnosis
  • Phobia, Social* / epidemiology
  • Prevalence
  • Substance-Related Disorders* / epidemiology